Belongs to

• Solid Tumor Oncology Division

Types of Work

["2022"]

[[["Journal Articles",446],["Meeting Abstracts",429],["Reviews",26],["Editorials",8],["Guidelines",8],["Book Sections",6],["Miscellaneous",6],["Research Letters",6],["Correspondences",2],["Books Whole",1]]]

[938]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• humans
• major clinical study
• male
• middle aged

Recent Works

1. Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma

   Journal Article

   Movva, S.; Seier, K.; Bradic, M.; Charalambous, K.; Rosenbaum, E.; Kelly, C. M.; Cohen, S. M.; Hensley, M. L.; Avutu, V.; Banks, L. B.; more...
   Journal for ImmunoTherapy of Cancer (2025)

   Fulltext@MSK | Save
2. Phase I study of the mutant IDH1 inhibitor ivosidenib: Long-term safety and clinical activity in patients with conventional chondrosarcoma

   Journal Article

   Tap, W. D.; Cote, G. M.; Burris, H.; Gore, L.; Elias, A.; Beeram, M.; Conley, A. P.; Gianolio, D. A.; Qu, Z.; Pandya, S.; more...
   Clinical Cancer Research (2025)

   Fulltext@MSK | Save
3. Letetresgene autoleucel in advanced/metastatic myxoid/round cell liposarcoma

   Journal Article

   D'Angelo, S. P.; Druta, M.; Van Tine, B. A.; Liebner, D.; Schuetze, S. M.; Tap, W. D.; Preston, J.; Goodison, S.; D'Souza, J. W.; Kapoor, G. S.; more...
   Journal of Clinical Oncology (2025)

   Fulltext@MSK | Save